These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing. Frias-Staheli N; Dorner M; Marukian S; Billerbeck E; Labitt RN; Rice CM; Ploss A J Virol; 2014 Feb; 88(4):2205-18. PubMed ID: 24335303 [TBL] [Abstract][Full Text] [Related]
4. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. Perry ST; Buck MD; Lada SM; Schindler C; Shresta S PLoS Pathog; 2011 Feb; 7(2):e1001297. PubMed ID: 21379341 [TBL] [Abstract][Full Text] [Related]
5. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines. Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106 [TBL] [Abstract][Full Text] [Related]
6. Mouse models of dengue virus infection and disease. Yauch LE; Shresta S Antiviral Res; 2008 Nov; 80(2):87-93. PubMed ID: 18619493 [TBL] [Abstract][Full Text] [Related]
7. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. Cox J; Mota J; Sukupolvi-Petty S; Diamond MS; Rico-Hesse R J Virol; 2012 Jul; 86(14):7637-49. PubMed ID: 22573866 [TBL] [Abstract][Full Text] [Related]
8. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection. Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123 [TBL] [Abstract][Full Text] [Related]
9. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules. Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J mBio; 2017 Aug; 8(4):. PubMed ID: 28765218 [TBL] [Abstract][Full Text] [Related]
11. Mouse models of dengue virus infection for vaccine testing. Sarathy VV; Milligan GN; Bourne N; Barrett AD Vaccine; 2015 Dec; 33(50):7051-60. PubMed ID: 26478201 [TBL] [Abstract][Full Text] [Related]
12. Mouse models for dengue vaccines and antivirals. Plummer EM; Shresta S J Immunol Methods; 2014 Aug; 410():34-8. PubMed ID: 24440090 [TBL] [Abstract][Full Text] [Related]
13. A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection. Costa VV; Fagundes CT; Valadão DF; Cisalpino D; Dias AC; Silveira KD; Kangussu LM; Ávila TV; Bonfim MR; Bonaventura D; Silva TA; Sousa LP; Rachid MA; Vieira LQ; Menezes GB; de Paula AM; Atrasheuskaya A; Ignatyev G; Teixeira MM; Souza DG PLoS Negl Trop Dis; 2012; 6(5):e1663. PubMed ID: 22666512 [TBL] [Abstract][Full Text] [Related]
14. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses. Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564 [TBL] [Abstract][Full Text] [Related]
15. Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response. Marcos E; Lazo L; Gil L; Izquierdo A; Suzarte E; Valdés I; Blanco A; Ancizar J; Alba JS; Pérez Yde L; Cobas K; Romero Y; Guillén G; Guzmán MG; Hermida L Immunol Lett; 2016 Aug; 176():51-6. PubMed ID: 27233365 [TBL] [Abstract][Full Text] [Related]
16. Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment. Pu SY; Xiao F; Schor S; Bekerman E; Zanini F; Barouch-Bentov R; Nagamine CM; Einav S Antiviral Res; 2018 Jul; 155():67-75. PubMed ID: 29753658 [TBL] [Abstract][Full Text] [Related]
17. A protective role for dengue virus-specific CD8+ T cells. Yauch LE; Zellweger RM; Kotturi MF; Qutubuddin A; Sidney J; Peters B; Prestwood TR; Sette A; Shresta S J Immunol; 2009 Apr; 182(8):4865-73. PubMed ID: 19342665 [TBL] [Abstract][Full Text] [Related]
18. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771 [TBL] [Abstract][Full Text] [Related]